GRW-06 · SEC. 10 Marketing & Growth

Generate a Cold Outreach Sequence From a Real ICP and Pain Point

Turn one specific ICP and a sourced pain point into a 3-email sequence that isn't generic spam.

FORMAT: prompt
DIFFICULTY: intermediate
TIME: 15 min
TOOLS: universal
MODELS: any
COPIES: 0 so far

When to use this

You've identified a specific ICP segment and a real, sourced pain point (from interviews, support patterns, or lost-deal notes) and need a first-touch outreach sequence for it. Not for "write me a cold email template," which produces the same spam everyone already deletes.

The pattern

Pastes as plain text

Write a 3-email cold outreach sequence from the ICP, pain point, and offer I give you.

Structure:
Email 1 (Day 0): Open with an observation about their specific situation, not "hope this finds you well." End with one low-friction ask: a question they can answer in one line, not a meeting request.
Email 2 (Day 3, if no reply): Lead with the proof point. If I said "no proof yet," write the line NEED PROOF POINT instead of inventing a number or client name. Lower the ask further: a yes/no question.
Email 3 (Day 7, if no reply): A breakup email. Give them permission to say not now, leave the door open, no guilt-tripping.

Rules:
- No flattery ("I love what you're doing"), no fake urgency, no "just circling back."
- Each email under 120 words.
- Subject line under 6 words, no clickbait.
- If the pain point I gave you is too generic to write from ("companies struggle with growth"), tell me instead of writing generic copy anyway.
- Use a named prospect's release dates, tools, or company behavior only when I supplied a
  verified source for it; otherwise use a role-level observation or write
  `[PERSONALIZATION: verify a relevant public fact]`.

Start by asking me for these in one message, then wait: (1) the ICP (role, company size/type, the tool or process they use today), (2) the pain point, something I actually observed or heard, not a guess, (3) our offer in one sentence, plus a proof point with a real number, or "no proof yet" if there isn't one.

Real example output

ICP: Head of Support at 50-200 person B2B SaaS companies running Zendesk.
Pain point: ticket volume spikes 3-4x during release weeks and they have no way to predict staffing needs ahead of time, so they're either overstaffed most weeks or scrambling during releases.
Proof: one team cut release-week overtime hours by 60% using our release-calendar integration.

**Email 1, Day 0**
Subject: release week staffing

Release weeks can turn a normal support rotation into a scramble when ticket volume jumps.

Quick question: do you staff release weeks differently than normal weeks right now, or is it the same rotation every time?

**Email 2, Day 3**
Subject: re: release week staffing

One support team we work with was scheduling overtime for every release until they connected their release calendar to their staffing plan. That cut release-week overtime hours by 60% in the first quarter.

Would connecting release dates to staffing plans be useful for your team?

**Email 3, Day 7**
Subject: closing the loop

Haven't heard back, so I'll assume release-week staffing isn't a priority right now. Totally fine. If that changes, I'm easy to find. Good luck with the next release.

Why it works

Requiring a sourced pain point up front, and forcing the model to flag a generic one instead of writing around it, is what keeps this out of spam territory. The declining-ask structure (question, then yes/no, then permission to close) matches how real replies happen instead of pushing a meeting from email one.

Related patterns

MKT-03Target User Segment BreakdownTurn a rough audience description into grounded user segments with needs, objections, and buying triggers.INT-07Competitor Complaint MiningMine a competitor's negative reviews for weaknesses that recur, are recent, and a buyer would switch over.GRW-09Turn Your Product's Real Activation Steps Into an Onboarding Email SequenceGive it your actual activation funnel steps, get one nudge email per step, not a generic welcome series.